These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19737846)

  • 1. Scientific and logistical challenges in designing the CONTROL trial: recombinant factor VIIa in severe trauma patients with refractory bleeding.
    Dutton R; Hauser C; Boffard K; Dimsitts J; Bernard G; Holcomb J; Leppäniemi A; Tortella B; Bouillon B;
    Clin Trials; 2009 Oct; 6(5):467-79. PubMed ID: 19737846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
    Selin S; Tejani A
    Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
    Hauser CJ; Boffard K; Dutton R; Bernard GR; Croce MA; Holcomb JB; Leppaniemi A; Parr M; Vincent JL; Tortella BJ; Dimsits J; Bouillon B;
    J Trauma; 2010 Sep; 69(3):489-500. PubMed ID: 20838118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced mortality by meeting guideline criteria before using recombinant activated factor VII in severe trauma patients with massive bleeding.
    Payen JF; Berthet M; Genty C; Declety P; Garrigue-Huet D; Morel N; Bouzat P; Riou B; Bosson JL;
    Br J Anaesth; 2016 Oct; 117(4):470-476. PubMed ID: 28077534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of thromboelastometry and recombinant factor VIIa in trauma.
    Bartal C; Yitzhak A
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):281-8. PubMed ID: 19390255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global differences in causes, management, and survival after severe trauma: the recombinant activated factor VII phase 3 trauma trial.
    Christensen MC; Parr M; Tortella BJ; Malmgren J; Morris S; Rice T; Holcomb JB;
    J Trauma; 2010 Aug; 69(2):344-52. PubMed ID: 20699743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
    Kluger Y; Riou B; Rossaint R; Rizoli SB; Boffard KD; Choong PI; Warren B; Tillinger M
    Crit Care; 2007; 11(4):R85. PubMed ID: 17686152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
    Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
    Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of recombinant-activated factor VII in bleeding trauma patients.
    Dutton RP; Conti BM
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based Emergency Medicine/Critically Appraised Topic. The efficacy of recombinant activated factor VII in severe trauma.
    Nishijima DK; Zehtabchi S
    Ann Emerg Med; 2009 Nov; 54(5):737-744.e1. PubMed ID: 19285753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current evidence based guidelines for factor VIIa use in trauma: the good, the bad, and the ugly.
    Duchesne JC; Mathew KA; Marr AB; Pinsky MR; Barbeau JM; McSwain NE
    Am Surg; 2008 Dec; 74(12):1159-65. PubMed ID: 19097529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients.
    Dutton RP; Hess JR; Scalea TM
    J Clin Anesth; 2003 May; 15(3):184-8. PubMed ID: 12770653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.
    Mohr AM; Holcomb JB; Dutton RP; Duranteau J
    Crit Care; 2005; 9 Suppl 5(Suppl 5):S37-42. PubMed ID: 16221318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIIa (recombinant) for acute traumatic hemorrhage.
    Patanwala AE
    Am J Health Syst Pharm; 2008 Sep; 65(17):1616-23. PubMed ID: 18714107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework.
    Moltzan CJ; Anderson DA; Callum J; Fremes S; Hume H; Mazer CD; Poon MC; Rivard G; Rizoli S; Robinson S
    Transfus Med; 2008 Apr; 18(2):112-20. PubMed ID: 18399845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes.
    McMullin NR; Wade CE; Holcomb JB; Nielsen TG; Rossaint R; Riou B; Rizoli SB; Kluger Y; Choong PI; Warren B; Tortella BJ; Boffard KD;
    J Trauma; 2010 Jul; 69(1):60-9. PubMed ID: 20622579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uses of recombinant factor VIIa in trauma.
    Stein DM; Dutton RP
    Curr Opin Crit Care; 2004 Dec; 10(6):520-8. PubMed ID: 15616396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage.
    Boffard KD; Choong PI; Kluger Y; Riou B; Rizoli SB; Rossaint R; Warren B;
    Transfusion; 2009 Dec; 49 Suppl 5():240S-7S. PubMed ID: 19954486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant factor VIIa: review of current "off license" indications and implications for practice.
    Rose L
    AACN Adv Crit Care; 2007; 18(2):141-8. PubMed ID: 17473542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion.
    Spinella PC; Perkins JG; McLaughlin DF; Niles SE; Grathwohl KW; Beekley AC; Salinas J; Mehta S; Wade CE; Holcomb JB
    J Trauma; 2008 Feb; 64(2):286-93; discussion 293-4. PubMed ID: 18301188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.